The Donald Y. M. Leung-JACI Clinical and Translational Research Fund
Background: Dr. Donald Leung, is the Editor-in-Chief of The Journal of Allergy and Clinical Immunology (JACI) and has served for the past 15 years. Under his leadership, the impact factor of our journal has risen from 3.7 to 12.047, reflecting a marked improvement in publications of research dedicated to the diagnosis and treatment of allergic and immunologic diseases. JACI is the most highly cited Journal in the field of Allergy, Asthma and Clinical Immunology and is the most visible official publication of The American Academy of Allergy, Asthma and Immunology (AAAAI). With the recent decline in NIH funding and restrictions from other funding sources, it is critical to establish new sources of research funding to maintain outstanding research in the field of allergy and clinical immunology. Without outstanding research, there is a threat to the advancement of new treatments in diseases seen by experts in the Allergy-Immunology specialty. The quality of research in Allergy-Clinical Immunology could drop due to an erosion of talented researchers and clinicians in the allergy, asthma and immunology field.
As one of his initiatives to support and enhance research in allergy and immunology and maintain JACI’s high impact factor, he and the ARTrust are initiating a new $4,000,000 research fund. The “Donald Y. M. Leung, MD, PhD-JACI ARTrust Partnership Lecture” commemorates the launch of this effort and the opportunity to advance the knowledge and treatment of allergy, asthma and immunologic diseases by providing a perpetual source of funding for research. The vision is to support quality, cutting edge translational and basic research suitable for publication in JACI and further advance patient care and the credibility of allergy / immunology. We encourage all individuals interested in securing the future of scientifically based patient care to consider donating to this exciting new funding opportunity. The ARTrust has committed $500,000 of dollar for dollar matching funds from within the existing corpus. This match may increase to $1 million dollars in matching funds to create a fund of $2 million on our way to grow $4 million to support clinical and translational research in perpetuity. The faster we grow the fund, the quicker awards can be provided. Our vision is to have the first awards at the time Dr. Donald Leung’s term as Editor ends. Please join the individuals who have already committed over $300,000 to make this vision a reality. We encourage you to celebrate the contributions of Dr. Donald Leung, the other JACI Editors and editorial staff and the success of JACI with a generous donation to the The Donald Y. M. Leung-JACI Clinical and Translational Research Fund through the ARTrust website. Together we can do more. A contribution to ARTrust is “Investing Together in our Future”
If you are interested in contributing to the The Donald Y. M. Leung-JACI Clinical and Translational Research Fund online click here or if you prefer to send a check click here. For more information call the ARTrust office and ask for Charlotte at 414-272-6071.